Advertisement

Topics

Lung Cancer Video Library – 2017 The Changing Landscape of First Line Treatment for EGFR Mutation-Positive NSCLC

11:00 EST 3 Dec 2017 | GRACE

Jack West, MD, President and CEO of GRACE provides updates to our Lung Cancer Video Library. In this recent video, Dr. West discusses the changing landscape of first-line treatment for EGFR mutation-positive non-small cell lung cancer (NSCLC).

Original Article: Lung Cancer Video Library – 2017 The Changing Landscape of First Line Treatment for EGFR Mutation-Positive NSCLC

NEXT ARTICLE

More From BioPortfolio on "Lung Cancer Video Library – 2017 The Changing Landscape of First Line Treatment for EGFR Mutation-Positive NSCLC"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...

Cancer Disease
Cancer is not just one disease but many diseases. There are more than 100 different types of cancer. Most cancers are named for the organ or type of cell in which they start - for example, cancer that begins in the colon is called colon cancer; cancer th...

Gilotrif (afatinib)
GILOTRIF (afatinib) is a kinase inhibitor indicated for the first-line treatment of patients with metastatic non-small cell lung cancer (NSCLC) whose tumors have epidermal growth factor receptor (EGFR) exon 19 deletions or exon 21 (L8...